1. Xiao G#, Ren H*.Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B. J Hepatol.2024 （IF: 26.8）

2. Xiao G#, Ren H*. A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B: Is cirrhosis driving the performance? J Hepatol. 2024 （IF: 26.8）

3. Zha G#, Chen Z#, Wu N, Huang T, Deng Z, Cai D, Peng M, Hu P, Ren H*.Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.J Med Virol. 2024（IF: 12.7）

4.Wu N#, Chen Z#, Zha G, Deng Z, Huang W, Cai D, Peng M, Hu P*, Tang L*, Ren H*. Clinical and immunological features of COVID-19 in patients with anti-MDA5dermatomyositis during the omicron wave in Chongqing, China. J Med Virol.2024（IF: 12.7）

5.Tan A, He Y, Zhou Y, Peng X, Chang Y, Peng M, Ren H*, Xu H*. A potential antiviral role for CCR5+CD8+ T cells in children with hepatitis B. J Med Virol.2024（IF: 12.7）

6. Song R#, Wang X#, Li Z#, Wu H#, Tan J, Tan J, Li H, Zeng T, Ren H*, Chen Z*. ALTA: a simple nutritional prognostic score for patients with hepatitis B virus-related acute-on-chronic liver failure. Front Nutr. 2024（IF: 5.7）

7.Li D, Fang Q, Chen Z, Tang J, Tang H, Cai N, Qiu K, Zhu M, Yang X, Yang L, Yang Y, Huang Y, Lei X, Zhang H, Lin Q, Mao Q, Xu T, Li Y, Zheng Y, Peng M*, Hu P*.  Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients. Front Pharmacol. 2024（IF=4.4）

8.Zhiwei Chen#,Yuting Wang#,Taiyu He,Hu Li,Ling Ao,Qingbo Pan,Yingzhi Zhou,Qian Zhu,Dejuan Xiang,Gaoli Zhang,Ning Ling,Min Chen,Peng Hu,Mingli Peng,Dachuan Cai,Dazhi Zhang*,Hong Ren*.Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases.J Clin Transl Hepatol.2024（IF=3.6）

9.Wang CR, Liu XQ, Shen W, Zhong GC, Li H, Tang Q, Liu YX, Hu P*. Profiles of HBcrAg and pgRNA in Pregnant Women With Chronic HBV Under Different Disease Phases and Antiviral Prophylaxis. Open Forum Infect Dis.2024（IF=3.8）

10.Yu P, Yang H, Li H, Mei Y, Wu Y, Cheng H, Su H, Deng Y, Jiang T, He Z, Hu P. Sigmoidal relationship between liver fat content and nonalcoholic fatty liver disease in Chinese adults. Postgrad Med J. 2024（IF=3.6）

11.Wei Shen#, Botond Sipos, and Liuyang Zhao.SeqKit2: A Swiss Army Knife for Sequence and Alignment Processing. iMeta.2024(IF: 23.7)

12.Li F，Han XJ，Wu CX，He JH，Liu H，Li SH，Li L，Long XL，Sun H* .Evaluation of immune and pyroptosis status in a model of sepsis-induced secondary pneumonia.Int Immunopharmacol.2024（IF=4.8）

13.Jinglin Tang#,Jiaxuan Zhang#,Gaoli Zhang,Wenhui Peng,Ning Ling,Yingzhi Zhou,Hongmei Xu,Hong Ren,Min Chen*.（2024）Stat3 activation-triggered transcriptional networks govern the early stage of HBV-induced hepatic inflammation.mBio.2024 （IF=5.1）

14.Taiyu He#,Dazhi Zhang*.（2024）Non-linear association of baseline viral load with ontreatment hepatocellular carcinoma risk in chronic hepatitis B: still needs further discussion.Gut.2024（IF=24.5）

15.He Taiyu#, Zhang Dazhi*.（2024）Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk-A multinational cohort study of HBeAg-positive patients. Hepatology.2024（IF=14）

16.Chaojing Wen,Yixuan Wang,Haoyue Tian,Yu Lei,Zhiyi Wang,Dachuan Cai,Zhi Zhou,Xiaofeng Shi*.Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study.Front Cell Infect Microbiol.2024（IF=4.1）

17.Rui Song,Zhao Li,Yingzhi Zhang,Jiahe Tan,Zhiwei Chen*.（2024）Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults.Liver Int.2024（IF=6.7）

18.Lin Guo,Jia-Jun Liu,Shao-Yuan Long,Pei-Yun Wang,Shan Li,Jin-Lan Wang,Xia-Fei Wei,Jie Li,Ling Lei*,Ai-Long Huang*,Jie-Li Hu*.TIM22 and TIM29 inhibit HBV replication by up-regulating SRSF1 expression. Journal of Medical Virology.2024(IF=12.7)

19.Jie-Li Hu#,Ai-Long Huang*.Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics..Virologica Sinca.2024(IF=5.5)

20.Zerui Yang#,Jingyan Zeng#,Yueyue Chen#,Mengchun Wang,Hongchun Luo,Ai-Long Huang*,Haijun Deng*,Yuan Hu*. Detection of HBV DNA integration in plasma cell-free DNA of different HBV diseases utilizing DNA capture strategy. Virologica Sinica.2024(IF=4.3)

21.Zhongqi Feng#,Jiaxin Yin#,Zhirong Zhang#,Zhen Chen,Luyi Huang*,Ni Tang*,Kai Wang*.O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.Oncogene.2024(IF=8)

22.Lihui Wang#,Runda Xu#,Daosheng Huang#,Pai Peng#,Keyong Sun#,Jie Hu,Bei-Zhong Liu,Liang Fang,Liwen Zhang,Xin Sun,Fei Gu,Ni Tang*,Ai-Long Huang*,Xin Lin*,Xun Lan*.Identification of virus epitopes and reactive T-cell receptors from memory T cells without peptide synthesis.

communications biology.2024(IF=5.2)

23.Yu-Wei Luo#,Jiang-Peng Zhou#,Hongyu Ji#,Doudou Xu,Anqi Zheng,Xin Wang,Zhizheng Dai,Zhicheng Luo,Fang Cao,Xing-Yue Wang,Yunfang Bai,Di Chen,Yueming Chen,Qi Wang,Yaying Yang,Xinghai Zhang,Sandra Chiu,Xiaozhong Peng*,Ai-Long Huang*,Kai-Fu Tang*.SARS-CoV-2 N protein-induced Dicer, XPO5, SRSF3, and hnRNPA3 downregulation causes pneumonia.Nature communications.2024(IF=14.7)

24.Yu-Wei Luo#,Hongyu Ji,Ai-Long Huang*,Kai-Fu Tang*.Communication between small cytosolic dsDNA and autophagy inhibits CGAS (cyclic GMP-AMP synthase) activation.Autophagy.2024(IF=14.6)

25.Zhizheng Dai#,Hongyu Ji#,Anqi Zheng#,Ai-Long Huang*,Kai-Fu Tang*.Protocol for isolating small cytosolic dsDNA from cultured murine cells.STAR protocols.2024(IF=1.3)

26.Shimei Shen#,Wen Wang#,Yuanyan Ma#,Shilei Wang#,Shaocheng Zhang#,Xuefei Cai,Liang Chen,Jin Zhang,Yalan Li,Xiaoli Wu,Jie Wei,Yanan Zhao*,Ailong Huang*,Siqiang Niu*,Deqiang Wang*.Affinity molecular assay for detecting Candida albicans using chitin affinity and RPA-CRISPR/Cas12a.Nat Commun.2024(IF=14.6)

27.Dan Nie#,Xin Tang#,Haijun Deng#,Xiaojun Yang#,Junji Tao,Fengli Xu,Yi Liu,Kang Wu,Kai Wang*,Zhechuan Mei*,Ailong Huang*,Ni Tang*.Metabolic enzyme SLC27A5 regulates PIP4K2A pre-mRNA splicing as a noncanonical mechanism to suppress hepatocellular carcinoma metastasis.Advanced Science.2024(IF=15.1)

28.Rui Liu#,Yi Liu#,Wenlu Zhang#,Guiji Zhang#,Zhirong Zhang,Luyi Huang,Ni Tang*,Kai Wang*.PCK1 attenuates tumor stemness via activating the Hippo signaling pathway in hepatocellular carcinoma.Genes & Diseases.2024(IF=6.8)

29.Zhirong Zhang#,Jiayao Yang#,Rui Liu#,Jing Ma,Kai Wang*,Xiaojun Wang*,Ni Tang*.Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling.Genes & Diseases.

2024(IF=6.8)

30.Mingang Pan#,Muyu Luo#,Lele Liu#,Yunmeng Chen,Ziyi Cheng,Kai Wang,Luyi Huang,Ni Tang,Jianguo Qiu*,Ailong Huang*,Jie Xia*.EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL.Journal of Experimental & Clinical Cancer Research.2024(IF=11.3)

31.Yuting Yang#,Jie Hu#,Haijun Deng#,Dapeng Chen,Guojin Wu,Huiwu Xing,Yuanyuan Liu,Shan Li,Yihan Yan,Ni Tang*,Yao Zhao*.Maternal Preconception COVID-19 Vaccination and Its Protective Effect on Infants after a Breakthrough Infection during Pregnancy.Vaccines.2024(IF=5.2)